-
Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus)
Mohammed Salisu Suleiman, Joseph Eniola Olajide, Jamila Audu Omale, Okpachi Christopher Abbah and Daniel Ocholi Ejembi
Research Article: Clinical Investigation
-
Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus)
Mohammed Salisu Suleiman, Joseph Eniola Olajide, Jamila Audu Omale, Okpachi Christopher Abbah and Daniel Ocholi Ejembi
Research Article: Clinical Investigation
-
Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus)
Mohammed Salisu Suleiman, Joseph Eniola Olajide, Jamila Audu Omale, Okpachi Christopher Abbah and Daniel Ocholi Ejembi
Research Article: Clinical Investigation
-
Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus)
Mohammed Salisu Suleiman, Joseph Eniola Olajide, Jamila Audu Omale, Okpachi Christopher Abbah and Daniel Ocholi Ejembi
Research Article: Clinical Investigation
-
Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus)
Mohammed Salisu Suleiman, Joseph Eniola Olajide, Jamila Audu Omale, Okpachi Christopher Abbah and Daniel Ocholi Ejembi
Research Article: Clinical Investigation
-
Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus)
Mohammed Salisu Suleiman, Joseph Eniola Olajide, Jamila Audu Omale, Okpachi Christopher Abbah and Daniel Ocholi Ejembi
Research Article: Clinical Investigation
-
Improving the implementation of evidence-based knowledge in healthcare
Bernard Burnand
Editorial: Clinical Investigation
-
Improving the implementation of evidence-based knowledge in healthcare
Bernard Burnand
Editorial: Clinical Investigation
-
Improving the implementation of evidence-based knowledge in healthcare
Bernard Burnand
Editorial: Clinical Investigation
-
Improving the implementation of evidence-based knowledge in healthcare
Bernard Burnand
Editorial: Clinical Investigation
-
Improving the implementation of evidence-based knowledge in healthcare
Bernard Burnand
Editorial: Clinical Investigation
-
Improving the implementation of evidence-based knowledge in healthcare
Bernard Burnand
Editorial: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Research Update: Clinical Investigation
-
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Research Update: Clinical Investigation
-
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Research Update: Clinical Investigation
-
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Research Update: Clinical Investigation
-
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Research Update: Clinical Investigation
-
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Research Update: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation